Image
Practice Point
Treatment planning imaging – PET
For patients who are considered suitable for active treatment and in whom staging of locally advanced (stage III) breast cancer is required or there is a high index of suspected metastatic breast cancer, consider the use of 18F-FDG positron emission tomography (PET).
PET scan can be useful for the evaluation of metastatic disease in locally advanced breast tumours with a high chance of (micro or macro) metastatic disease
How this guidance was developed
This practice point was developed using an expert consensus process informed by a potential source recommendation from KCE 2013 (Belgium) guideline (evidence review to January 2010) that was graded ‘Expert Opinion’. The practice point was also informed by the introduction of the MBS item for PET, which is restricted to patients with a high index of suspicion.
Treatment planning imaging – PET
Practice Point
For patients who are considered suitable for active treatment and in whom staging of locally advanced (stage III) breast cancer is required or there is a high index of suspected metastatic breast cancer, consider the use of 18F-FDG positron emission tomography (PET).
Principles in action
Safe and quality care
This practice point was developed using an expert consensus process informed by a potential source recommendation from KCE 2013 (Belgium) guideline (evidence review to January 2010) that was graded ‘Expert Opinion’. The practice point was also informed by the introduction of the MBS item for PET, which is restricted to patients with a high index of suspicion.